Myxedema is a distinctive swelling of the skin and underlying tissues that develops when the body is severely starved of thyroid hormone. The name literally refers to what is happening at a microscopic level: sugary gel-like substances accumulate in the skin, making it thicken, puff up, and feel waxy or dough-like. The term has also become a loose synonym for severe hypothyroidism itself, which can be confusing because the condition affects far more than the skin. Understanding what myxedema actually involves, how it differs from ordinary swelling, and when it becomes life-threatening helps make sense of a word that gets tossed around in multiple clinical contexts.
What Is Happening Inside the Skin
In a healthy person, thyroid hormones help regulate how quickly cells turn over molecules in connective tissue. When those hormones drop severely, cells called fibroblasts overproduce large sugar-protein molecules known as glycosaminoglycans, especially hyaluronic acid. These molecules are extremely good at attracting and holding water. As they pile up in the dermis, they drag water into the tissue with them, creating a puffy, non-pitting edema that feels fundamentally different from the kind you get with heart failure or kidney disease.
If you press a finger into ordinary edema, you leave a dent that slowly fills back in. In myxedema, pressing the skin does not leave a lasting dent because the swelling is not just trapped fluid; it is a gel-like matrix of hyaluronic acid and water woven into the tissue itself.1PubMed Central. Thyroid hormone action on skin This is the hallmark that gave the condition its name. Studies of myxedematous skin also show that the elastic fibers in the dermis become both fewer and structurally abnormal, contributing to the coarsened, thickened texture that doctors can sometimes spot on visual inspection alone.2JAMA Internal Medicine. Altered Skin Elastic Fibers in Hypothyroid Myxedema and Pretibial Myxedema
Beyond the skin’s surface, the same protein-and-water accumulation extends to deeper tissues. Vocal cords can thicken, producing the characteristic hoarse, low-pitched voice many patients develop. The tongue may enlarge. Fluid can collect around the heart or in joint spaces. In one investigation, researchers found that people in a hypothyroid state had a dramatically increased mass of albumin sitting outside their blood vessels, along with sluggish lymphatic drainage that could not clear the excess. All of these abnormalities reversed with thyroid hormone replacement.3N Engl J Med. Mechanisms of edema formation in myxedema–increased protein extravasation and relatively slow lymphatic drainage
Signs That Reach Beyond the Skin
Because thyroid hormone influences virtually every organ system, severe hypothyroidism rarely announces itself with skin changes alone. The classic picture includes fatigue, cold intolerance, constipation, weight gain, dry hair, and mental sluggishness. But the cardiovascular effects deserve special attention because they can be serious even before someone reaches the crisis stage of myxedema coma.
Thyroid hormone directly affects heart rate and the strength of each heartbeat. When levels crash, the heart slows down and pumps less forcefully. Fluid can also accumulate inside the pericardium, the sac surrounding the heart, creating what is called a pericardial effusion. In severe hypothyroidism, these effusions can grow surprisingly large. One case described a patient with undiagnosed Hashimoto’s thyroiditis who was found to have a large pericardial effusion with mildly reduced heart function.4American Journal of Case Reports. Large Pericardial Effusion Secondary to Generalized Myxedema from Undiagnosed Hashimoto’s Thyroiditis Despite their size, these effusions rarely cause the dangerous compression of the heart known as tamponade, though echocardiographic images sometimes look alarming enough to suggest it.5Journal of the Endocrine Society. Myxedema Heart and Pseudotamponade
Myxedema Madness and Other Psychiatric Effects
One of the more unsettling aspects of severe hypothyroidism is its ability to mimic psychiatric illness. The phenomenon has been recognized for well over a century and goes by the vivid name “myxedema madness.” Psychiatric presentations can range from cognitive dysfunction and depression all the way to frank psychosis, with hallucinations, paranoia, and disorganized thinking.6PubMed Central. Hypothyroidism Presenting as Psychosis: Myxedema Madness Revisited
This matters because patients sometimes end up in psychiatric care before anyone checks their thyroid. A pooled analysis described the term “myxedema psychosis” as specifically referring to psychotic symptoms arising in untreated hypothyroidism.7PubMed Central. Myxedema Psychosis: Systematic Review and Pooled Analysis In one illustrative case, a 60-year-old woman developed new-onset psychosis after she had stopped taking her thyroid hormone replacement 20 years after a thyroidectomy. She was initially admitted to a psychiatric ward before the underlying cause was identified.8PubMed Central. Myxedema Psychosis: Diagnostic Challenges and Management Strategies in Hypothyroidism-Induced Psychosis The good news is that thyroid hormone replacement typically resolves the psychiatric symptoms, provided the diagnosis is caught. The bad news is that the diagnosis is easy to miss when psychosis is the presenting complaint.
Myxedema Coma
Myxedema coma is the most dangerous endpoint of untreated or severely undertreated hypothyroidism, and the name is slightly misleading because patients do not always arrive in a literal coma. Many present with progressively altered consciousness, extreme hypothermia, dangerously slow heart rate, low blood pressure, and depressed breathing. It is rare, but the mortality rate is high even with treatment, which makes quick recognition critical.
A precipitating event almost always pushes a chronically hypothyroid person over the edge. Common triggers include infections, cold exposure, trauma, surgery, and the discontinuation of thyroid supplements.9PubMed Central. Myxedema coma: a new look into an old crisis In tropical regions, infections and stopping thyroid medication are the dominant triggers, since ambient cold is less of a factor.10Endocrine Abstracts. Myxedema coma triggered by a urinary tract infection: a case report
Because the condition is rare and its features overlap with other emergencies like sepsis, a diagnostic scoring system has been developed to help clinicians. The system evaluates disturbances in temperature regulation, mental status, cardiovascular function, gastrointestinal function, metabolic state, and whether a precipitating event is present. In the study that originally proposed this scoring system, a score of 60 or above identified myxedema coma with full sensitivity and about 86% specificity.11PubMed. A diagnostic scoring system for myxedema coma A recent European consensus statement endorsed this score as a useful clinical tool while cautioning that similarly high scores can appear in other critical illnesses, so it should be interpreted alongside bloodwork confirming hypothyroidism rather than used in isolation.12European Thyroid Journal. Management of endocrine emergencies: joint consensus statement for management of myxoedema coma
Treatment needs to start on clinical suspicion alone, without waiting for lab confirmation, because delay costs lives. The standard approach combines intravenous thyroid hormone with stress-dose glucocorticoids, since adrenal insufficiency can coexist with severe hypothyroidism and giving thyroid hormone alone could trigger an adrenal crisis.13European Thyroid Journal. Management of endocrine emergencies: joint consensus statement for management of myxoedema coma Supportive care includes passive rewarming, ventilatory support, and treating whatever infection or event triggered the crisis in the first place.
Diagnostic delay remains a real problem, particularly when another acute condition is present at the same time. In one documented case, an 83-year-old man was found unresponsive and initially treated for what appeared to be a stroke; imaging confirmed multiple cerebellar infarcts and severe artery disease in the brain. Only when he failed to improve did clinicians discover the underlying myxedema coma, which had been precipitated by the ischemic brain injury itself.14PubMed Central. Delayed Diagnosis of Myxedema Coma in a Patient With Concurrent Severe Intracranial Atherosclerotic Disease
Pretibial Myxedema, the Counterintuitive Cousin
Here is where the terminology gets genuinely confusing. Pretibial myxedema involves the same kind of glycosaminoglycan buildup in the skin, but it occurs on the shins and is associated not with hypothyroidism but with Graves’ disease, the most common form of hyperthyroidism. In other words, one type of myxedema comes from too little thyroid hormone and the other is linked to too much. The shared name reflects the shared skin pathology, not the shared thyroid state.
The mechanism involves autoimmune antibodies directed at the TSH receptor. In Graves’ disease, these antibodies stimulate the thyroid to overproduce hormone, but the TSH receptor also exists on fibroblasts in certain tissues, especially the skin of the lower legs and the tissue behind the eyes. When antibodies bind to fibroblasts in the shin area, they stimulate those cells to pump out glycosaminoglycans, producing localized thickened, waxy, sometimes nodular skin lesions. Research has confirmed that patients with pretibial myxedema carry higher levels of TSH receptor antibodies and that fibroblasts from affected skin actually have TSH receptor binding sites on their surface, pointing to a shared antigenic target between the thyroid and the skin.15PubMed. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor
A case-control study of Graves’ disease patients with apparently normal-looking pretibial skin found something striking: even without visible lesions, about half of the patients showed histological signs of skin changes, including mucin deposition, collagen splitting, and lymphocyte infiltration around blood vessels. Nearly half had all three features present simultaneously.16PubMed Central. Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin This suggests that pretibial myxedema may be considerably more common in Graves’ disease than clinical examination alone would indicate.
Treatment of pretibial myxedema differs from the generalized form. Topical or intralesional corticosteroids are the mainstay. One series of 32 patients treated with intralesional immunomodulating therapy found that all achieved complete remission, with about a fifth resolving after just one round of treatment and most others responding within two to four sessions.17PubMed Central. Treatment of pretibial myxedema with intralesional immunomodulating therapy Topical corticosteroids applied under occlusive wrapping, combined with managing the underlying thyroid disease, have also been reported to flatten and shrink lesions.18PubMed Central. Pretibial myxedema in Grave’s disease: A case report and treatment review of the literature
Treating the Underlying Hypothyroidism
For generalized myxedema caused by hypothyroidism, the definitive treatment is thyroid hormone replacement, almost always with levothyroxine. The swelling, skin changes, cardiovascular effects, and psychiatric symptoms are all reversible once adequate thyroid levels are restored, though full recovery can take weeks to months depending on how severe and how prolonged the deficiency was.
Starting doses vary widely. Someone with mild or subclinical disease might begin on 25 to 50 micrograms daily, while a person with no residual thyroid function, such as after surgical removal of the gland, often needs a full replacement dose of roughly 1.6 micrograms per kilogram of body weight per day.19PubMed Central. Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient’s Lifetime In elderly patients or those with heart disease, doctors typically start low and increase gradually to avoid straining the heart. The goal is to bring TSH levels back into the normal range while monitoring for both undertreated and overtreated states.
One of the most underappreciated risks is treatment interruption. The 60-year-old woman described earlier who developed psychosis had simply stopped taking her replacement pills. People who have had thyroidectomies or radioactive iodine ablation depend on exogenous thyroid hormone for the rest of their lives, and discontinuation is a well-established trigger for myxedema coma. Even patients with Hashimoto’s thyroiditis, whose remaining thyroid tissue slowly burns out over years, can deteriorate rapidly if they stop their medication during an intercurrent illness.
Myxedema in Newborns
Congenital hypothyroidism occurs in roughly 1 in 4,000 newborns, and untreated, it causes irreversible brain damage.20Hormone Research. Neonatal Screening for Congenital Hypothyroidism: Results and Perspectives Newborn screening programs that measure TSH from a heel prick shortly after birth have been one of the most successful public health interventions in pediatric endocrinology. When treatment with thyroxine begins within the first two weeks of life at appropriate doses, brain damage is prevented even if evidence suggests the hypothyroidism began in the womb, because maternal thyroid hormone crossing the placenta provides a degree of protection during fetal development.
Myxedema in infants can present in unusual ways. One documented case involved a newborn with laryngeal myxedema, where the glycosaminoglycan buildup occurred in the tissues of the voice box and caused subglottic stenosis, a narrowing of the airway just below the vocal cords. The baby presented with signs of upper airway obstruction, and the unusual appearance of the narrowing, combined with a thyroid goiter and a positive newborn screening result, led to the diagnosis.21PubMed. Laryngeal myxedema as a cause of reversible subglottic stenosis in a newborn Like myxedema elsewhere in the body, the airway narrowing was reversible with thyroid hormone replacement.
How the Term Evolved
The word “myxedema” (sometimes spelled “myxoedema” in British usage) was coined in 1878 by William Ord, a physician at St. Thomas Hospital in London, to describe the clinical syndrome we now recognize as hypothyroidism.22Hormone Research in Paediatrics. History of the Thyroid “Myx” comes from the Greek word for mucus or slime, referring to the gelatinous material Ord observed in the tissues. At the time, nobody knew what the thyroid did, and the link between the gland and the syndrome had yet to be established. Descriptions of what was almost certainly hypothyroidism had appeared even earlier, with one noted case dating to 1850.23PubMed Central. Hypothyroidism and thyroid substitution: historical aspects
The breakthrough came in 1891, when George Murray demonstrated that injecting thyroid extract from sheep improved the symptoms of a woman with myxedema.24Hormone Research in Paediatrics. History of the Thyroid This was one of the earliest successful hormone replacement therapies in medicine and established the principle that the thyroid gland secreted something essential that could be supplied externally. Over the following decades, the active thyroid hormones were isolated and eventually synthesized, leading to the modern levothyroxine tablets used today.
The persistence of the term “myxedema” in clinical language, despite it technically referring to a skin finding, reflects this history. For a long time, the visible skin changes were the defining feature doctors used to identify severe hypothyroidism, so the skin condition and the systemic disease became linguistically fused.
Conditions That Mimic Myxedema
Several other conditions deposit similar mucin-like substances in the skin and can be mistaken for myxedema. Scleromyxedema is one example. It causes widespread thickening and hardening of the skin due to mucin deposition and fibroblast proliferation, but it is unrelated to the thyroid. It is associated with an abnormal protein in the blood (a paraprotein) rather than thyroid dysfunction. The histological features differ enough from hypothyroid myxedema that a skin biopsy can usually distinguish the two, but the clinical appearance can overlap.25PubMed Central. Scleromyxoedema and Thyroid Disease: A Case Report
Systemic sclerosis (scleroderma) also causes skin thickening, though through a different mechanism involving collagen overproduction rather than glycosaminoglycan accumulation. Nephrotic syndrome and heart failure produce generalized edema that can superficially resemble myxedema but is pitting rather than non-pitting and is driven by fluid dynamics rather than tissue composition. The non-pitting quality of myxedematous swelling remains the simplest bedside clue, though a thyroid function test will settle the question quickly.
For pretibial myxedema specifically, the differential includes other causes of localized skin thickening on the lower legs, such as chronic venous insufficiency, lymphedema, and certain granulomatous diseases. The association with Graves’ disease, particularly when eye disease is also present, usually points clinicians in the right direction, and a biopsy showing mucin deposition with characteristic collagen changes confirms the diagnosis.